A method for rapid determination of zotepine by gas chromatography-mass spectrometry

Therapeutic Drug Monitoring

Volumn 18, Issue 3, 1996, Pages 294-296

  Tanaka, O ^a   Kondo, T ^a   Kaneko, S ^a   Mihara, K ^a   Otani, K ^a   Tokinaga, N ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Gas chromatography mass spectrometry; Pharmacokinetics; Solid phase extraction; Zotepine

Indexed keywords

ZOTEPINE;

ARTICLE; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; ENTEROHEPATIC CIRCULATION; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PSYCHOSIS;

ANTIPSYCHOTIC AGENTS; CALIBRATION; DIBENZOTHIAZEPINES; DIBENZOTHIEPINS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; HUMANS;

EID: 0029950718     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199606000-00013     Document Type: Article

References (7)

1. Lieberman JA. Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development. Br J Psychiatry 1993;163(suppl 22): 7-18.
2. Noda K, Suzuki A, Okui M, Noguchi H, Nishiura M, Nishiura N. Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man. Arzneimittelforschung 1979;29: 1595-600.
3. Kondo T, Otani K, Ishida M, et al. A study of the therapeutic spectrum of a fixed dose of zotepine and its relationship with serum concentrations of the drug. Hum Psychopharmacol 1993;8:133-9.
4. Barnas C, Stuppäck CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol. Int Clin Psychopharmacol 1992;7:23-7.
5. Fleischhacker WW, Barnas C, Stuppäck CH, Unterweger B, Miller C, Hinterhuber H. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial. Psychopharmacol Bull 1989;25:97-100.
6. Otani K, Kondo T, Kaneko S, Hirano T, Mihara K, Fukushima Y. Steady-state serum kinetics of zotepine. Hum Psychopharmacol 1992;7:331-6.
7. Dahl M-L, Llerena A, Bondesson U, Lindström L, Bertilsson L. Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms. Br J Clin Pharmacol 1994;37:71-4.